Skip to main content

Cyclosporin A in der Behandlung von multipler Sklerose und Myasthenie

  • Chapter
  • 8 Accesses

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Neurologie ((VDGNEUROLOGIE,volume 4))

Zusammenfassung

Immunsuppressiva haben in den letzten Jahren eine zunehmende Bedeutung in der mehr und mehr therapeutisch ausgerichteten klinischen Neurologie erhalten.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aimar G, Confavreux C, Ventre JJ, Guillot M, Devic M (1983) Etude de 213 cas de sclerose en plaques traités purl’azathioprine de 1967 à 1982. Rev Neurol 139:509–513

    Google Scholar 

  2. Borel JF (1981) Cyclosporin A -present experimental status. Transplant Proc 13:344–348

    PubMed  CAS  Google Scholar 

  3. Borel JF, Feurer C, Gubler HU, Staehelin H (1976) Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 6/4: 468–475

    Article  Google Scholar 

  4. Borel JF, Ryffel B (1985) The mechanism of action of cyclosporin: A continuing puzzle. In: Schindler R (ed) Cyclosporin in autoimmune diseases. Springer, Berlin Heidelberg New York Tokyo, pp 24–30

    Chapter  Google Scholar 

  5. Colombani PM, Robb A, Hess AD (1985) Cyclosporine binding to calmodulin: A possible site of action on T lymphocytes. Science 228:337–339

    Article  PubMed  CAS  Google Scholar 

  6. Dommasch D, Depisch R, Pflughaupt W, Kappos L, Krauseneck P (1984) Demonstration of cyclosporin A in the CSF of multiple sclerosis patients. Clin Res Unit MS Ann Rep 2:26

    Google Scholar 

  7. Donatsch P, Abisch E, Homberger M (1981) A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay 2:19–32

    Article  PubMed  CAS  Google Scholar 

  8. Faakerley JK, Webb HE (1985) Cyclosporin, blood-brain-barrier, and multiple sclerosis. Lancet II:889–890

    Article  Google Scholar 

  9. Graffenried B von, Harrison WB (1985) Cyclosporin in autoimmune disease -side effets (with emphasis on venal dysfunction) and recommandations for use. In: Schindler R (ed) Cyclosporin in autoimmune diseases. Springer, Berlin Heidelberg New York Tokyo, pp 59–73

    Chapter  Google Scholar 

  10. Handschumacher ER, Harding MW, Rice J, Drugge RJ (1984) Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 226: 544–547

    Article  PubMed  CAS  Google Scholar 

  11. Kappos L (1983) Selbstbeurteilungsskala für Befindlichkeitsveränderungen bei Multipler Sklerose. Psycho 9:362–363

    Google Scholar 

  12. Kastrukoff LF, Paty DW (1984) A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis. Ann Neurol 15:250–256

    Article  PubMed  CAS  Google Scholar 

  13. Kurtzke JF (1983) Rating neurologic impairment in MS: An expanded disability status scale (EDSS). Neurology 33:1444–1452

    PubMed  CAS  Google Scholar 

  14. Mertens HG, Hertel G, Reuther P, Ricker K (1981) Effects of immunosuppressive drugs (Azathioprine). Ann NY Acad Sci 377:691–699

    Article  PubMed  CAS  Google Scholar 

  15. Patzold U, Hecker H, Pocklington P (1982) Azathioprine in treatment of multiple sclerosis. Final results of a 4 1/2 year controlled study of its effectiveness covering 115 patients. J Neurol Sci 54: 377–394

    Article  PubMed  CAS  Google Scholar 

  16. Reinherz EL, Weiner HL, Hauser SL, Cohen JA, Distaso JA, Schlossman SF (1980) Loss of suppressor T cells in multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med 303:125–129

    Article  PubMed  CAS  Google Scholar 

  17. Rogers AJ, Kahan BD (1984) Mechanisms of action and clinical application of cyclosporin in organ transplantation. Clinics Imm All 4:217–258

    Google Scholar 

  18. Rudge P (1985) The use of cyclosporin in multiple sclerosis -trial design and tolerance. In: Schindler R (ed) Cyclosporin in autoimmune diseases. Springer, Berlin Heidelberg New York Tokyo, pp 83–87

    Chapter  Google Scholar 

  19. Russell DH, Matrisian L, Kibler R, Larson DF, Poulos B, Magun BE (1984) Prolactin receptors on human lymphocytes and their modulation by cyclosporin. Biochem Biophys Res Commun 121:899–906

    Article  PubMed  CAS  Google Scholar 

  20. Schumacher GA, Beebe G, Kibler RF et al. (1965) Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. An NY Acad Sci 122:552–568

    Article  Google Scholar 

  21. Tindall RSA, Rollins JR, Phillips JT, Grennlee RG, Belendiuk G (1986) Double blind, placebo-controlled trial to determine the efficacy of cyclosporin A in the treatment of myasthenia gravis. Neurology 36(Suppl 1)

    Google Scholar 

  22. Valderrama R, Eggers A, Stracher A, Kaldany RRJ, Kao PN (1986) Therapie in experimental myasthenia gravis. Muscle Nerve (Suppl) 86:157

    Google Scholar 

  23. Wekerle H (1985) Mysthenia gravis -Zelluläre Grundlagen von immunologischer Selbsttoleranz und Autoimmunität. Fortschr Myol 4/2:33–37

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kappos, L. (1987). Cyclosporin A in der Behandlung von multipler Sklerose und Myasthenie. In: Poeck, K., Hacke, W., Schneider, R. (eds) Neuroimmunologie Spinale Krankheiten Neuropsychologie Metabolische Enzephalopathien Neurologische Notfälle Interventionelle Neuroradiologie. Verhandlungen der Deutschen Gesellschaft für Neurologie, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83201-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83201-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18254-2

  • Online ISBN: 978-3-642-83201-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics